Major depressive disorder Trials in Baltimore, United States
Conditions / Major depressive disorder / Baltimore, United States
Clinical trials for Major depressive disorder investigate a range of treatment strategies and patient populations.
74 total trials for this combination
Showing top 10 of 74 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00278941 | Quetiapine Fumarate as Monotherapy in the Maintenance Treatment of Patients With Major Depressive Disorder | COMPLETED | PHASE3 |
| NCT01436175 | SPD489 Adult Major Depressive Disorder (MDD) Open-label Safety and Tolerability Rollover Extension Study | TERMINATED | PHASE3 |
| NCT00006286 | Treatment for Adolescents With Depression Study (TADS) | COMPLETED | PHASE3 |
| NCT01153347 | A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder | COMPLETED | PHASE3 |
| NCT01085812 | Relapse-Prevention Study With Levomilnacipran ER (F2695 SR) in Patients With Major Depressive Disorder | COMPLETED | PHASE3 |
| NCT04855747 | A Study to Assess the Efficacy and Safety of REL-1017 as Adjunctive Treatment for Major Depressive Disorder (MDD) | TERMINATED | PHASE3 |
| NCT03113968 | ELEKT-D: Electroconvulsive Therapy (ECT) vs. Ketamine in Patients With Treatment Resistant Depression (TRD) | COMPLETED | PHASE2/PHASE3 |
| NCT03288714 | Adaptive Design Study of NEST sTMS in Subjects With Major Depressive Disorder | COMPLETED | NA |
| NCT01152554 | A Study to Assess the Long- Term Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder | COMPLETED | PHASE3 |
| NCT06011577 | Randomized, Double-Blind, Placebo-Controlled Trial of REL-1017 as Adjunctive Treatment for MDD | TERMINATED | PHASE3 |